ADPT
Adaptive Biotechnologies Corp
NASDAQ · Healthcare · Biotechnology · US
$26.63
+3.20%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 2449.77x
- P/S forward
- 12.60x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 29.73x
- Price / sales
- 13.79x
- Price / cash flow
- -202.26x
Enterprise value
- Enterprise value
- $4.3B
- EV / sales
- 14.03x
- EV / EBITDA
- -270.85x
- EV / EBIT
- -115.41x
- Market cap
- $4.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026